US Stock MarketDetailed Quotes

GT Biopharma (GTBP)

Watchlist
  • 0.3127
  • -0.0099-3.07%
Close May 13 16:00 ET
  • 0.3127
  • 0.00000.00%
Pre 04:00 ET
11.14MMarket Cap-0.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GT Biopharma (GTBP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.52%12.42M
48.68%5.6M
-6.16%3.38M
-61.26%1.51M
-37.50%1.93M
5.80%14.36M
18.78%3.76M
15.44%3.6M
7.87%3.91M
-15.66%3.09M
Selling and administrative expenses
4.48%8.95M
130.17%4.22M
19.63%2.75M
-45.81%1.15M
-64.00%833K
20.48%8.57M
1.21%1.83M
30.66%2.3M
39.06%2.12M
14.84%2.31M
-General and administrative expense
----
----
19.63%2.75M
-45.81%1.15M
-64.00%833K
----
----
--2.3M
39.06%2.12M
--2.31M
Research and development costs
-40.12%3.47M
-28.70%1.38M
-51.49%634K
-79.65%363K
41.44%1.1M
-10.33%5.8M
42.23%1.93M
-4.18%1.31M
-14.84%1.78M
-52.91%777K
Operating profit
13.52%-12.42M
-48.68%-5.6M
6.16%-3.38M
61.26%-1.51M
37.50%-1.93M
-5.80%-14.36M
-18.78%-3.76M
-15.44%-3.6M
-7.87%-3.91M
15.66%-3.09M
Net non-operating interest income expense
-101.00%-4K
-286.44%-110K
-62.50%36K
-63.81%38K
-77.46%32K
-29.10%402K
-67.22%59K
-55.56%96K
-52.05%105K
395.83%142K
Non-operating interest income
-69.40%123K
-71.19%17K
-62.50%36K
-63.81%38K
-77.46%32K
-48.46%402K
-67.22%59K
-55.56%96K
-52.27%105K
-13.41%142K
Non-operating interest expense
--127K
----
----
----
----
--0
--0
--0
--0
--0
Other net income (expense)
-2,091.00%-15.93M
95.77%-3K
11,905.15%11.65M
-31,631.87%-28.69M
64.57%1.12M
-85.22%800K
-373.08%-71K
-80.20%97K
-93.55%91K
-80.41%683K
Gain on sale of security
-69.88%241K
95.77%-3K
139.18%232K
-196.61%-114K
-80.79%126K
-83.49%800K
-1,283.33%-71K
-80.20%97K
-91.55%118K
-77.79%656K
Special income (charges)
---27.74M
--0
--0
---28.74M
--998K
--0
--0
--0
--0
--0
-Less:Other special charges
--27.74M
--0
----
--28.74M
---998K
----
----
----
----
----
Other non- operating income (expenses)
--11.57M
--0
--11.41M
677.78%156K
----
----
----
----
---27K
--27K
Income before tax
-115.42%-28.35M
-51.21%-5.71M
343.30%8.3M
-713.18%-30.17M
65.75%-776K
-73.25%-13.16M
-27.45%-3.78M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
Income tax
Net income
-115.42%-28.35M
-51.21%-5.71M
343.30%8.3M
-713.18%-30.17M
65.75%-776K
-73.25%-13.16M
-27.45%-3.78M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
Net income continuous Operations
-115.42%-28.35M
-51.21%-5.71M
343.30%8.3M
-713.18%-30.17M
65.75%-776K
-73.25%-13.16M
-27.45%-3.78M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
Minority interest income
Net income attributable to the parent company
-115.42%-28.35M
-51.21%-5.71M
343.30%8.3M
-713.18%-30.17M
65.75%-776K
-73.25%-13.16M
-27.45%-3.78M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
Preferred stock dividends
320K
91K
144K
85K
Other preferred stock dividends
5.78M
1.72M
4.06M
0
0
0
Net income attributable to common stockholders
-161.73%-34.45M
-99.10%-7.52M
220.11%4.1M
-715.47%-30.25M
65.75%-776K
-73.25%-13.16M
-27.45%-3.78M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
Basic earnings per share
3.75%-6.68
82.27%-0.2944
167.97%1.04
-403.23%-10.92
79.88%-0.33
-23.05%-6.94
23.50%-1.66
13.56%-1.53
-45.64%-2.17
-680.95%-1.64
Diluted earnings per share
3.75%-6.68
82.27%-0.2944
167.97%1.04
-403.23%-10.92
79.88%-0.33
-23.05%-6.94
23.50%-1.66
13.56%-1.53
-45.64%-2.17
-680.95%-1.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.52%12.42M48.68%5.6M-6.16%3.38M-61.26%1.51M-37.50%1.93M5.80%14.36M18.78%3.76M15.44%3.6M7.87%3.91M-15.66%3.09M
Selling and administrative expenses 4.48%8.95M130.17%4.22M19.63%2.75M-45.81%1.15M-64.00%833K20.48%8.57M1.21%1.83M30.66%2.3M39.06%2.12M14.84%2.31M
-General and administrative expense --------19.63%2.75M-45.81%1.15M-64.00%833K----------2.3M39.06%2.12M--2.31M
Research and development costs -40.12%3.47M-28.70%1.38M-51.49%634K-79.65%363K41.44%1.1M-10.33%5.8M42.23%1.93M-4.18%1.31M-14.84%1.78M-52.91%777K
Operating profit 13.52%-12.42M-48.68%-5.6M6.16%-3.38M61.26%-1.51M37.50%-1.93M-5.80%-14.36M-18.78%-3.76M-15.44%-3.6M-7.87%-3.91M15.66%-3.09M
Net non-operating interest income expense -101.00%-4K-286.44%-110K-62.50%36K-63.81%38K-77.46%32K-29.10%402K-67.22%59K-55.56%96K-52.05%105K395.83%142K
Non-operating interest income -69.40%123K-71.19%17K-62.50%36K-63.81%38K-77.46%32K-48.46%402K-67.22%59K-55.56%96K-52.27%105K-13.41%142K
Non-operating interest expense --127K------------------0--0--0--0--0
Other net income (expense) -2,091.00%-15.93M95.77%-3K11,905.15%11.65M-31,631.87%-28.69M64.57%1.12M-85.22%800K-373.08%-71K-80.20%97K-93.55%91K-80.41%683K
Gain on sale of security -69.88%241K95.77%-3K139.18%232K-196.61%-114K-80.79%126K-83.49%800K-1,283.33%-71K-80.20%97K-91.55%118K-77.79%656K
Special income (charges) ---27.74M--0--0---28.74M--998K--0--0--0--0--0
-Less:Other special charges --27.74M--0------28.74M---998K--------------------
Other non- operating income (expenses) --11.57M--0--11.41M677.78%156K-------------------27K--27K
Income before tax -115.42%-28.35M-51.21%-5.71M343.30%8.3M-713.18%-30.17M65.75%-776K-73.25%-13.16M-27.45%-3.78M-41.18%-3.41M-86.24%-3.71M-898.24%-2.27M
Income tax
Net income -115.42%-28.35M-51.21%-5.71M343.30%8.3M-713.18%-30.17M65.75%-776K-73.25%-13.16M-27.45%-3.78M-41.18%-3.41M-86.24%-3.71M-898.24%-2.27M
Net income continuous Operations -115.42%-28.35M-51.21%-5.71M343.30%8.3M-713.18%-30.17M65.75%-776K-73.25%-13.16M-27.45%-3.78M-41.18%-3.41M-86.24%-3.71M-898.24%-2.27M
Minority interest income
Net income attributable to the parent company -115.42%-28.35M-51.21%-5.71M343.30%8.3M-713.18%-30.17M65.75%-776K-73.25%-13.16M-27.45%-3.78M-41.18%-3.41M-86.24%-3.71M-898.24%-2.27M
Preferred stock dividends 320K91K144K85K
Other preferred stock dividends 5.78M1.72M4.06M000
Net income attributable to common stockholders -161.73%-34.45M-99.10%-7.52M220.11%4.1M-715.47%-30.25M65.75%-776K-73.25%-13.16M-27.45%-3.78M-41.18%-3.41M-86.24%-3.71M-898.24%-2.27M
Basic earnings per share 3.75%-6.6882.27%-0.2944167.97%1.04-403.23%-10.9279.88%-0.33-23.05%-6.9423.50%-1.6613.56%-1.53-45.64%-2.17-680.95%-1.64
Diluted earnings per share 3.75%-6.6882.27%-0.2944167.97%1.04-403.23%-10.9279.88%-0.33-23.05%-6.9423.50%-1.6613.56%-1.53-45.64%-2.17-680.95%-1.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -